Navellier & Associates’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
Other funds holding THC
GCM
CCM
CCA
Navellier & Associates's THC Position: Q4 2022 in Review
Navellier & Associates sold out of Tenet Healthcare (THC) in Q4 2022, closing a stake of 5,025 shares — an estimated $259K sold.
Navellier & Associates first reported a position in THC in Q4 2021 and held it in 4 quarters. The position peaked at $484K in Q4 2021. 354 funds tracked by Wall St. Rank hold THC as of Q4 2022.
- Navellier & Associates reported no remaining Tenet Healthcare position as of Q4 2022 after selling out during the quarter.
- Navellier & Associates sold 5,025 Tenet Healthcare shares in Q4 2022, an estimated $259K.
- Navellier & Associates first reported a position in Tenet Healthcare in Q4 2021 and held it in 4 quarters.
- Navellier & Associates's Tenet Healthcare position peaked at $484K in Q4 2021.
- 354 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2022.
Based on Navellier & Associates's 13F filing for Q4 2022, filed 2 Feb 2023.